Research Article
A Comprehensive Evaluation of miR-144-3p Expression and Its Targets in Laryngeal Squamous Cell Carcinoma
Table 3
The pathway analysis using the 14 targets of miR-144-3p in LSCC.
| Gene set | Description | Size | value | Genes |
| R-HSA-3000170 | Syndecan interactions | 2 | 0.00041 | ITGA6, TNC | R-HSA-3000171 | Nonintegrin membrane-ECM interactions | 2 | 0.001957 | ITGA6, TNC | hsa04512 | ECM-receptor interaction | 2 | 0.003367 | ITGA6, TNC | R-HSA-216083 | Integrin cell surface interactions | 2 | 0.004174 | ITGA6, TNC | R-HSA-1474244 | Extracellular matrix organization | 3 | 0.004174 | ITGA6, TNC, FBN2 | hsa04151 | PI3K-Akt signalling pathway | 3 | 0.005336 | ITGA6, TNC, IRS1 | R-HSA-74713 | IRS activation | 1 | 0.005674 | IRS1 | hsa05206 | MicroRNAs in cancer | 2 | 0.01091 | IRS1, TNC | hsa04510 | Focal adhesion | 2 | 0.01872 | ITGA6, TNC | hsa04960 | Aldosterone-regulated sodium reabsorption | 1 | 0.040011 | IRS1 |
|
|